Model projects higher lifetime healthcare use with statins
Compared with no statins, lifetime simulations projected 0.64 to 0.94 additional years of life and an eventual rise in cumulative healthcare use.
Our read
Interventions- Studied:
- Computational study of people with or without prior cardiovascular disease, against no statins
- What changed:
- Cumulative healthcare use initially decreased with statin treatment but transitioned into higher long-term use against no statins
- In the record:
- The 602nd paper on statins with results in people; 1,830 on record in all. Its result on cardiovascular disease agrees with 33 of 35 other findings on record; 2 point the other way.
- Why it’s aging research:
- It studies an intervention with evidence of extending healthy life.
Editor of record: Boris Djordjevic · AgingResearch.News
A computational modeling study used UK Biobank data on hospital admissions for 501,807 people and primary care for 192,983 people. Researchers simulated lifetime healthcare use with and without statins in people aged 40 to 60 or 60 to 70, with or without prior cardiovascular disease—disease of the heart and blood vessels.
The simulations projected fewer major vascular events and lower annual rates of hospital bed-days. Cumulative use of every included healthcare service initially decreased, but the reductions shrank over time and eventually became increases. The authors linked the greater long-term use to longer survival. Older people and those with prior cardiovascular disease had larger reductions and earlier transitions to increased cumulative use.
Why it matters
Preventive care in middle and older age raises a planning question: how should health services account for both avoided disease and longer survival?
Caveats
These were lifetime projections from a model informed by cohort data, not healthcare-use outcomes observed in a randomized trial.
The paper
Impact of Preventive Treatment on Healthcare Use: A Modeling Study of Statin Treatment
University of Oxford; Queen Mary University of London
Value in Health, Jul 14, 2026, Open access
Comments
Be the first to comment.